Lovelace Biomedical And
Environmental Research Institute,
Inc.
Dba Inhalation Toxicology Research
Inst
CAGE Code: 2D703
NCAGE Code: 2D703
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 045911138
Summary
Lovelace Biomedical And, Environmental Research Institute,, Inc., Dba Inhalation Toxicology Research, Inst is an Active Commercial Supplier with the Cage Code 2D703 and is tracked by Dun & Bradstreet under DUNS Number 045911138..
Address
2425 Ridgecrest Dr Se
Albuquerque NM 87108-5129
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Department Of Energy General Office Supply Co Lanier Worldwide Inc Net Tek Inc Auto-Remote Back Up Systems We Build It Inc Laguna Construction Co Inc Silicon Heights Computers Inc. Tpl Inc La Marna Ruzinsky Barbara Editorial Kroker Engineering And Blue Skies Medical Supply Inc Gomez/Gomez Trucking Jones Veronica And Associates Aura Image Creators Alderete And Co Thiede Richard C Wheel Align It Ii Kwal-Howells Paint And Wallcoverings
Frequently Asked Questions (FAQ) for CAGE 2D703
- What is CAGE Code 2D703?
- 2D703 is the unique identifier used by NATO Organizations to reference the physical entity known as Lovelace Biomedical And Environmental Research Institute, Inc. Dba Inhalation Toxicology Research Inst located at 2425 Ridgecrest Dr Se, Albuquerque NM 87108-5129, United States.
- Who is CAGE Code 2D703?
- 2D703 refers to Lovelace Biomedical And Environmental Research Institute, Inc. Dba Inhalation Toxicology Research Inst located at 2425 Ridgecrest Dr Se, Albuquerque NM 87108-5129, United States.
- Where is CAGE Code 2D703 Located?
- CAGE Code 2D703 is located in Albuquerque, NM, USA.
Contracting History for CAGE 2D703 Most Recent 25 Records
- 75N92021F00001
- Gene Therapy Resource Program (Gtrp): Pharmacology/Toxicology Core Laboratory - Scientific Project For Rsa No. 2057 (Rader)
- 3 Sep 2021
- Gene Therapy Resource Program (Gtrp): Pharmacology/Toxicology Core Laboratory - Scientific Project For Rsa No. 2057 (Rader)
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $1,638,183.00
- Department Of Health And Human Services (Hhs)
- 75N95021F00001
- Characterization Of A Non-Paralyzing Bont-Based Biopharmaceutical For The Treatment Of Neuropathic Pain
- 24 Sep 2021
- Characterization Of A Non-Paralyzing Bont-Based Biopharmaceutical For The Treatment Of Neuropathic Pain
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $584,043.00
- Department Of Health And Human Services (Hhs)
- 75N95021F00002
- Efficacy And Safety Evaluation Of A Lead Gene Therapy Candidate In Methyl Melanomic Acidemia (Mmab) Disease Mouse Models And Bioanalytical Assay Methods Development.
- 28 Sep 2021
- Efficacy And Safety Evaluation Of A Lead Gene Therapy Candidate In Methyl Melanomic Acidemia (Mmab) Disease Mouse Models And Bioanalytical Assay Methods Development.
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $623,883.00
- Department Of Health And Human Services (Hhs)
- 75A50122F61001
- Support Non-Clinical Immunogenicity Studies Of Sars-Cov-2 Microneedle Patch Vaccines Candidates In A Small-Animal Model
- 23 Sep 2022
- Support Non-Clinical Immunogenicity Studies Of Sars-Cov-2 Microneedle Patch Vaccines Candidates In A Small-Animal Model
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $756,111.00
- Department Of Health And Human Services (Hhs)
- 75A50122F61001
- Support Non-Clinical Immunogenicity Studies Of Sars-Cov-2 Microneedle Patch Vaccines Candidates In A Small-Animal Model
- 8 Mar 2022
- Support Non-Clinical Immunogenicity Studies Of Sars-Cov-2 Microneedle Patch Vaccines Candidates In A Small-Animal Model
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $294,926.00
- Department Of Health And Human Services (Hhs)
- 75N92020F00002
- Gene Therapy Resource Program (Gtrp): Pharmacology/Toxicology Core Laboratory Project For Rsa No. 2034
- 16 Dec 2021
- Gene Therapy Resource Program (Gtrp): Pharmacology/Toxicology Core Laboratory Project For Rsa No. 2034
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $1,105,620.00
- Department Of Health And Human Services (Hhs)
- 75N95020F00003
- Natural History Studies In Neuromuscular Junction (Nmj) Disease Mouse Models.
- 8 Sep 2021
- Natural History Studies In Neuromuscular Junction (Nmj) Disease Mouse Models.
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $1,555,408.00
- Department Of Health And Human Services (Hhs)
- 75N95020F00001
- Non-Clinical Safety Assessment Of Gene Therapy (Pcca, Mmab, Dok7 And Colq) To Support Platform Gene Therapy For Congenital Myasthenic Diseases (Dok7, Colq) And Acidemia (Pcca, Mmab)
- 23 Sep 2020
- Non-Clinical Safety Assessment Of Gene Therapy (Pcca, Mmab, Dok7 And Colq) To Support Platform Gene Therapy For Congenital Myasthenic Diseases (Dok7, Colq) And Acidemia (Pcca, Mmab)
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $2,269,992.00
- Department Of Health And Human Services (Hhs)
- 75N95020F00001
- Non-Clinical Safety Assessment Of Gene Therapy (Pcca, Mmab, Dok7 And Colq) To Support Platform Gene Therapy For Congenital Myasthenic Diseases (Dok7, Colq) And Acidemia (Pcca, Mmab)
- 19 Nov 2021
- Non-Clinical Safety Assessment Of Gene Therapy (Pcca, Mmab, Dok7 And Colq) To Support Platform Gene Therapy For Congenital Myasthenic Diseases (Dok7, Colq) And Acidemia (Pcca, Mmab)
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $2,269,992.00
- Department Of Health And Human Services (Hhs)
- 75N95020F00004
- Characterization Of A Downstream Gene Therapeutic For The Reparative Treatment Of Severe Fractures.
- 24 Sep 2021
- Characterization Of A Downstream Gene Therapeutic For The Reparative Treatment Of Severe Fractures.
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $1,083,619.00
- Department Of Health And Human Services (Hhs)
- 75N95020F00004
- Characterization Of A Downstream Gene Therapeutic For The Reparative Treatment Of Severe Fractures.
- 3 Dec 2021
- Characterization Of A Downstream Gene Therapeutic For The Reparative Treatment Of Severe Fractures.
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $1,263,796.00
- Department Of Health And Human Services (Hhs)
- 75N95020F00002
- Characterization Of A Non-Addictive Small Molecule Therapeutics For The Management Of Non-Cancer Pain. Pop Sept. 18, 2020 - Sept. 17, 2022. Mod P00001: To Exercise An Option. Mod P00002: To Exercise Options. Mod P00003: To Exercise Option And Remove
- 30 Aug 2021
- Characterization Of A Non-Addictive Small Molecule Therapeutics For The Management Of Non-Cancer Pain. Pop Sept. 18, 2020 - Sept. 17, 2022. Mod P00001: To Exercise An Option. Mod P00002: To Exercise Options. Mod P00003: To Exercise Option And Remove
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $869,765.00
- Department Of Health And Human Services (Hhs)
- 75N92020F00001
- Gene Therapy Research Program (Gtrp) - Pharmacology/Toxicology Core Laboratory: Task Area D - Rsa No. 2041
- 28 Sep 2021
- Gene Therapy Research Program (Gtrp) - Pharmacology/Toxicology Core Laboratory: Task Area D - Rsa No. 2041
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $388,588.00
- Department Of Health And Human Services (Hhs)
- 75N92020F00001
- Gene Therapy Research Program (Gtrp) - Pharmacology/Toxicology Core Laboratory: Task Area D - Rsa No. 2041
- 19 Aug 2021
- Gene Therapy Research Program (Gtrp) - Pharmacology/Toxicology Core Laboratory: Task Area D - Rsa No. 2041
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $388,588.00
- Department Of Health And Human Services (Hhs)
- 75N92020F00001
- Gene Therapy Research Program (Gtrp) - Pharmacology/Toxicology Core Laboratory: Task Area D - Rsa No. 2041
- 7 Jul 2021
- Gene Therapy Research Program (Gtrp) - Pharmacology/Toxicology Core Laboratory: Task Area D - Rsa No. 2041
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $317,202.00
- Department Of Health And Human Services (Hhs)
- 75N93020F00001
- Pcmid B-07, Nonhuman Primate Model Development For Enterovirus D68 (Ev-D68)
- 21 Dec 2021
- Pcmid B-07, Nonhuman Primate Model Development For Enterovirus D68 (Ev-D68)
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $1,008,942.00
- Department Of Health And Human Services (Hhs)
- 75A50120F33002
- Project Rtor Bio-Amt-1021: Development Of Animal Models For Evaluation Of Medical Countermeasures For Sars-Cov-2
- 23 Jun 2021
- Project Rtor Bio-Amt-1021: Development Of Animal Models For Evaluation Of Medical Countermeasures For Sars-Cov-2
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $6,075,081.00
- Department Of Health And Human Services (Hhs)
- 75A50120F33002
- Project Rtor Bio-Amt-1021: Development Of Animal Models For Evaluation Of Medical Countermeasures For Sars-Cov-2
- 29 Jul 2021
- Project Rtor Bio-Amt-1021: Development Of Animal Models For Evaluation Of Medical Countermeasures For Sars-Cov-2
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $6,075,081.00
- Department Of Health And Human Services (Hhs)
- 75N93021D00007
- Eo14042 - The Contractor Shall Provide Preclinical Development Support For Candidate Products And Drug Development Activities.
- 12 Nov 2021
- Eo14042 - The Contractor Shall Provide Preclinical Development Support For Candidate Products And Drug Development Activities.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $0.00
- Department Of Health And Human Services (Hhs)
- 75N93021F00001
- The Purpose Of This Task Order Is To Fund The Guaranteed Minimum Amount Of The Contract.
- 13 Oct 2020
- The Purpose Of This Task Order Is To Fund The Guaranteed Minimum Amount Of The Contract.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $0.00
- Department Of Health And Human Services (Hhs)
- 75N93021F00001
- The Purpose Of This Task Order Is To Fund The Guaranteed Minimum Amount Of The Contract.
- 24 May 2021
- The Purpose Of This Task Order Is To Fund The Guaranteed Minimum Amount Of The Contract.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $0.00
- Department Of Health And Human Services (Hhs)
- 75N95019D00030
- Cro Support For Ncats Medicinal Chemistry For Lead Optimization.
- 18 Oct 2021
- Cro Support For Ncats Medicinal Chemistry For Lead Optimization.
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $0.00
- Department Of Health And Human Services (Hhs)
- 0001
- Omnibus Iii / O3-24
- 21 Jun 2022
- Omnibus Iii / O3-24
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $510,040.59
- Department Of Defense (Dod)
- HHSO10033002T
- Establishment Of A Minipig Model Of Ionizing Radiation-Induced Thrombocytopenia Coagulopathies And Measures Of Associated Vascular And Organ Injury
- 24 Jun 2021
- Establishment Of A Minipig Model Of Ionizing Radiation-Induced Thrombocytopenia Coagulopathies And Measures Of Associated Vascular And Organ Injury
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $5,101,883.86
- Department Of Health And Human Services (Hhs)
- HHSF22301006T
- Igf::Ot::Igf Cytotoxicity Of Common Solvents Used In Liquid Nicotine Formulations
- 11 Sep 2017
- Igf::Ot::Igf Cytotoxicity Of Common Solvents Used In Liquid Nicotine Formulations
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $1,149,919.00
- Department Of Health And Human Services (Hhs)